腫瘍性大腸炎による局所性プラズマリンパ腫 化学放射線治療後の長期寛解
Kentaro Hara1, Rina Hosoda1, Masaya Maegaki1
1Division of Hematology and Clinical Laboratory Medicine, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Japan.
Internal medicine (Tokyo, Japan)
|August 27, 2025
まとめ
血性リンパ腫 (PBL) は珍しい癌で,潰瘍性大腸炎 (UC) の患者で発生する可能性があります. このケーススタディは,化学療法と放射線療法による治療の成功を強調し,UCに関連するPBLの長期的な生存への希望を示しています.
科学分野:
- 腫瘍学
- 胃腸内科
- 血液学
背景:
- プラズマ芽細胞リンパ腫 (PBL) は,しばしばHIVと関連している攻撃的なB細胞リンパ腫です.
- 潰瘍性大腸炎 (UC) の背景に発生するPBLは極めてまれである.
- メサラジンやブデソニドなどのUCの長期治療は,二次悪性腫瘍との潜在的な関連性について調査されています.
研究 の 目的:
- HIV陽性で潰瘍性大腸炎 (UC) を発症した極まれな結腸プラズマリンパ腫 (PBL) の症例を報告する.
- この珍しい病気の 治療法と長期的な結果について
- UC患者の局所的なPBLに対する化学放射線療法の潜在的な有効性を評価する.
主な方法:
- 63歳のHIVネガティブの女性の 症例報告です
- メサラジンとブデソニドの長期治療後に結腸PBLの診断
- 化学療法と腹部放射線療法による治療
主要な成果:
- 患者は結腸PBLの完全寛解を達成しました.
- 治療後3年以上,再発は観察されなかった.
- この症例は,UCに関連したPBLの4番目の報告例であり,これまでで最も長い生存期間を示しています.
結論:
- メサラジンおよびブデソニドによる治療後でも,PBLはUCを有するHIV陰性患者で発生することがあります.
- 化学放射線治療は局所的なPBLの有効な治療方法であるようです.
- このケースは,UCにおけるこの珍しい腫瘍学的合併症の長期的な生存と管理に関する貴重なデータを提供している.
関連する概念動画
01:29Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
01:21Inflammatory Bowel Disease V: Surgical Management
206
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
206
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
316
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
316
01:17Chronic Bowel Disorders: Introduction
540
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
540
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264